Xtant Medical (XTNT) Proxy filing summary

Executive summary

• Annual meeting scheduled for August 7, 2026, in New York, with voting available online or in person.

• Shareholders are encouraged to review proxy materials and vote by August 6, 2026.

Voting matters and shareholder proposals

• Election of six director nominees to serve until the next annual meeting.

• Ratification of Grant Thornton LLP as independent auditor for the year ending December 31, 2026.

• Advisory (non-binding) vote on executive officer compensation.

• Proxies may vote on other business properly brought before the meeting.

Board of directors and corporate governance

• Six nominees listed for election to the board: John Bakewell, Jonn Beeson, Sean E. Browne, Abhinav Jain, Tyler P. Lipschultz, and Stavros Vizirgianakis.